Drug Topics
MARCH 5, 2025
Researchers investigated the acceptability of community pharmacy-led influenza vaccination and patients willingness to return for future immunization.
Hospital Pharmacy Europe
MARCH 4, 2025
Medication errors frequently occur in emergency departments (EDs), placing a burden on both patients and healthcare systems. Enhanced integration of pharmacists to multidisciplinary ED teams could alleviate physician workload and improve patient care and safety, a recent study has found. This qualitative study explored physicians experiences of collaborating with pharmacists who joined emergency ED teams in two Norwegian hospitals, while also gauging their views on making such collaboration perm
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
MARCH 3, 2025
Panelists discuss how pharmacists employ multiple strategies to support medication adherence in older adults with TD, including simplifying dosing regimens, utilizing medication synchronization programs, providing medication packaging solutions, conducting regular follow-up calls, and collaborating closely with prescribers and care teams to develop and adjust personalized treatment plans that address individual patient needs and barriers to care.
Pharma Marketing Network
MARCH 5, 2025
Introduction In the highly regulated world of pharmaceutical marketing , mastering Google Ads management can be a game-changer. With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. However, the landscape isnt simple.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
DiversifyRx
MARCH 4, 2025
I’m a pharmacy growth nerd. I’ve built businesses, consulted for pharmacies across the country, and helped owners take control of their profitability. If there’s a goal that can help your pharmacy thrive, you better believe I’m all over it. Because goals are the fastest way to bridge the gap between where your pharmacy is today and where you want it to be tomorrow.
Hospital Pharmacy Europe
MARCH 4, 2025
Some hormonal contraceptives are associated with a small but significant increased risk of stroke and myocardial infarction, according to a large and detailed study from Denmark. The analysis was based on national prescription records for more than two million Danish women between 1996 and 2021. It showed that contemporary oestrogen-progestin and progestin-only contraceptives were associated with an increased risk of arterial thrombotic events.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
The Checkup by Singlecare
MARCH 7, 2025
Baclofen is a muscle relaxant often prescribed to treat muscle spasms. Its often prescribed for people with muscle spasticity or tightness from multiple sclerosis , cerebral palsy, or certain types of spinal cord injuries. If you are taking baclofen, you might wonder whether its safe to drinkespecially if youre heading to an event where alcohol will be served.
IDStewardship
MARCH 7, 2025
In this article a clinical infectious diseases pharmacist reviews five things for pharmacists to know about measles in 2025. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP – – POST UNDER CONSTRUCTION – – Article posted 8 March 2025 This week on Tuesday night a few text messages came through on WhatsApp chats about how there was a measles case from a high school student here in the Miami area.
Hospital Pharmacy Europe
MARCH 5, 2025
More than half of patients are unsure when their asthma inhaler is empty, with some continuing to use the device when it is empty with serious implications for managing their condition, research has shown. A study measured the amount of medicine left in more than 2,600 pressurised metered-dose inhalers that had been returned for recycling and found many were returned under or overused.
STAT
MARCH 5, 2025
The recent postponement of a key federal advisory committee meeting is deeply alarming and signals that it may no longer be able to provide independent scientific guidance to federal agencies. The Advisory Committee on Immunization Practices (ACIP), has served the American people since 1964. ACIP advises the director of the Centers for Diseases Control and Prevention on how to use vaccines in the U.S. population to prevent the spread of infections, such as measles, influenza, whooping cough, and
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Checkup by Singlecare
MARCH 4, 2025
Lamotrigine (brand name Lamictal) is a prescription anticonvulsant that’s FDA approved to treat epilepsy and maintenance treatment of bipolar I disorder. It may also be prescribed off-label to treat schizophrenia , trigeminal neuralgia , and fibromyalgia. Lamotrigine works by stabilizing mood and preventing seizures, making it a vital part of treatment plans for individuals facing these conditions.
Oswald's
MARCH 6, 2025
While the retail pharmacy landscape continues to see independent locations shutter, were continuing to do everything we can to stay afloat and continue serving our wonderful community. As weve seen our customer base grow over the past year, Id love to share a quick history of my family & Oswalds past. The pharmacy’s journey began with my great-great-great grandfather, William Wallace Wickel.
Pharma Marketing Network
MARCH 5, 2025
Introduction Pharmaceutical marketing has changed. Traditional outreach methods are no longer enough to engage healthcare professionals (HCPs) and patients in a digital-first world. Thats where PPC advertising strategies come into play. But heres the challenge pharma PPC isnt like other industries. Regulatory restrictions, compliance concerns, and complex audience targeting make it one of the toughest sectors to master in digital advertising.
STAT
MARCH 5, 2025
Jazz Pharmaceuticals said Wednesday it would spend nearly $1 billion to buy Chimerix and its experimental pill for a devastating brain tumor that primarily affects children and young adults. The tumor, known as diffuse midline glioma, or DMG (and sometimes as DIPG depending on where it’s found), has flummoxed researchers for decades. It often wraps itself around a patient’s brain stem, preventing surgeons from safely excising it.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Checkup by Singlecare
MARCH 4, 2025
Qsymia and phentermine are medications commonly prescribed for weight loss. Qsymia is a brand-name drug that contains two active ingredients, phentermine and extended-release topiramate. Phentermine is a generic drug, commonly known by brand names Adipex-P and Lomaira. While both drugs are commonly used for weight management, they are not exactly the same.
PhRMA
MARCH 6, 2025
Lawmakers on both sides of the aisle are renewing a multi-year effort to crack down on drug middlemen, known as pharmacy benefit managers (PBMs). These middlemen control what patients pay at the pharmacy counter, where they can get their medicine, what medicines they can get and what hoops they must jump through. The effort in Congress reflects mounting pressure to hold PBMs accountable and help lower patients’ out-of-pocket costs.
The Thyroid Pharmacist
MARCH 7, 2025
We are exposed to so many toxins every day both inside and outside our homes (some are obvious, some less so). For those of us with Hashimotos, this toxin overload can be particularly problematic, as our bodies often struggle to eliminate toxins efficiently. [1] This inability to detox properly can trigger or worsen autoimmune symptoms, as these chemical exposures can trigger immune dysregulation. [2] This is why we need to be especially diligent when it comes to addressing chemical exposure in
STAT
MARCH 5, 2025
Against a backdrop of historical neglect and a future of political uncertainty, Science devoted a special issue to new research and perspectives on women’s health. The collection, published Wednesday , highlights studies on the interplay between hormones, chromosomes and dementia, including findings with implications for men as well as women.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Checkup by Singlecare
MARCH 7, 2025
On March 4, 2025, the U.S. Food and Drug Administration (FDA) announced its approval of the first generic form of Xarelto (rivaroxaban), a popular anticoagulant medication. The approval is for the 2.5 mg tablets prescribed to reduce the risk of major cardiovascular events in adults with coronary artery disease (CAD) and to reduce the risk of major thrombotic vascular events in adults with peripheral artery disease (PAD).
Pharma Marketing Network
MARCH 6, 2025
Introduction Pharmaceutical marketing has evolved. Traditional advertising methods alone no longer cut it in todays digital-first world. Social media advertising now plays a crucial role in reaching healthcare professionals (HCPs) and patients , allowing pharma brands to engage, educate, and build trust like never before. But heres the challenge: strict industry regulations make social media advertising tricky for pharma marketers.
Med Ed 101
MARCH 5, 2025
JD is a 58-year-old male with a history of cirrhosis due to alcohol-related liver disease. He has no medication allergies and is taking the following medications: Lactulose 30 mL twice daily, Spironolactone 100 mg daily, Furosemide 40 mg daily, Propranolol 20 mg twice daily JD presents to the clinic with complaints of frequent loose stools, […] The post Deprescribing in Cirrhosis – Case Study appeared first on Med Ed 101.
STAT
MARCH 4, 2025
The Food and Drug Administration scolded a company for a promotional display that falsely claimed its brand-name medicine was more effective than generic versions, which is apparently the first time the agency office responsible for monitoring advertising has cited such an issue. In a Feb. 3 letter posted on the FDA website this week, the Office of Prescription Drug Promotion wrote that Edenbridge Pharmaceuticals displayed a panel about its Hemady treatment for multiple myeloma in a conference e
Oswald's
MARCH 6, 2025
As we anticipate the beginning of the Spring season, most of us start thinking about cleaning and decluttering our homes, planting our gardens, or planning how to keep our children busy over spring break. We should also be thinking about cleaning or detoxing our body, more specifically, our liver. Our liver is an essential organ and plays a vital role in sustaining life.
European Pharmaceutical Review
MARCH 3, 2025
A team of researchers in Japan have developed a novel artificial photosynthesis method that transforms waste organic compounds into valuable pharmaceuticals and energy using sunlight and water. The approach, known as artificial photosynthesis directed toward organic synthesis (APOS), represents a major step forward in sustainable chemical manufacturing.
The FDA Law Blog
MARCH 6, 2025
By Adrienne R. Lenz, Principal Medical Device Regulation Expert & Lisa M. Baumhardt, Principal Medical Device Regulatory Expert In the past three months, FDA has released two guidance documents related to artificial intelligence (AI) enabled medical devices: (1) a final guidance titled Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions (PCCP Guidance, which we blogged about here ) was issued in December
STAT
MARCH 5, 2025
Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers compete for market share and try to draw patients away from compounding pharmacies that have been making cheaper copies of weight loss drugs. Wegovy normally carries a list price of about $1,350 a month, but Novo will sell the treatment through its new direct-to-consumer offering called NovoCare Pharmacy at $499 a month for all doses to ca
PharmD Live
MARCH 4, 2025
As value-based care (VBC) continues to shape the future of healthcare, managing high-risk patients efficiently is more important than ever. Chronic illnesses are the leading cause of death in the United States, accounting for 90% of the nations $4.5 trillion annual healthcare expenditures. Despite medical advancements, chronic disease management remains a significant challenge, contributing to avoidable hospitalizations, increased costs and lower quality performance scores for healthcare provide
European Pharmaceutical Review
MARCH 4, 2025
Four medicines were recommended for approval at the EMAs human medicines committee (CHMP)s February 2025 meeting. A marketing authorisation for Deqsiga (human normal immunoglobulin) was granted as a replacement therapy for primary or secondary immunodeficiencies and immunomodulation in individuals with certain autoimmune conditions. The group recommended authorisation of two medicines for oncology indications.
The FDA Law Blog
MARCH 6, 2025
By Andrew J. Hull Late last month, the Department of Justice filed a short statement regarding administrative law judges (ALJs). The statement, issued by the Departments Chief of Staff Chad Mizelle, states in its entirety: Today the Department of Justice determined that multiple layers of removal restrictions shielding administrative law judges (ALJs) are unconstitutional.
STAT
MARCH 3, 2025
The obesity medicine field has gained a new entrant, with AbbVie on Monday announcing it had licensed an experimental weight loss drug from a Danish company that is in a Phase 1 trial. The deal includes a $350 million upfront payment to the company, Gubra, for the rights to its drug, called for now GUB014295. AbbVie will pay up to some $1.9 billion if certain development and sales milestones are met.
Board Vitals - Pharmacist
MARCH 2, 2025
Are you ready for the ABIM Infectious Disease Certification Exam? Test your knowledge with five highly rated Infectious Disease board review questions (which you’ll find in our Infectious Disease board review question bank ) and see if you’re as prepared as you think you are. Good luck! Infectious Disease Practice Quiz Are you ready for the Infectious Disease Exam?
Drug Topics
MARCH 4, 2025
If CMS doesnt reconsider its mandate, which forces independent pharmacies to go deep into a hole and lose money, many of them will close.
The FDA Law Blog
MARCH 3, 2025
The American Conference Institutes 3rd Annual Forum on Advanced Therapeutics is scheduled to take place from March 19-20, 2025, at the Seaport Hotel in Boston, MA. The conference will bring together industry leaders to explore evolving market trends, regulatory frameworks, and intellectual property strategies shaping the future of advanced therapeutics.
Expert insights. Personalized for you.
Let's personalize your content